Literature DB >> 10419995

Intact dietary soy protein, but not adding an isoflavone-rich soy extract to casein, improves plasma lipids in ovariectomized cynomolgus monkeys.

K A Greaves, J S Parks, J K Williams, J D Wagner.   

Abstract

The dietary consumption of soy protein has been linked to a reduction in coronary heart disease and improvements in a number of related risk factors. Recent investigations have focused on isoflavone components of soy protein. The purpose of this study was to examine plasma lipids and lipoproteins, particularly LDL, with the intake of intact soy protein or casein-lactalbumin diets with and without a semipurified extract of soy, rich in isoflavones. Sixty ovariectomized cynomolgus monkeys were assigned to one of three groups fed diets containing the following: 1) casein-lactalbumin as the protein source (CAS; n = 20); 2) CAS plus a semipurified extract of soy, rich in isoflavones (ISO; n = 20); or 3) intact soy protein (SOY; n = 20) for 12 wk. Lipoproteins were fractionated by combined ultracentrifugation and HPLC. Isolated LDL particles were further subfractionated by dividing the LDL peak into three fractions for compositional analyses. The SOY group had significantly lower plasma total cholesterol, VLDL plus IDL cholesterol and LDL cholesterol, and significantly less HDL cholesterol than the CAS group. LDL particles from the SOY group had a significantly less cholesteryl ester than the CAS group. The semipurified extract of soy, rich in isoflavones, added to casein-lactalbumin protein did not have the same effects as intact soy protein on plasma lipids and lipoproteins. Other components of soy protein, either alone or in combination with isoflavones, may be involved in the effects seen in this study.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419995     DOI: 10.1093/jn/129.8.1585

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  11 in total

1.  Soy isoflavones reduce heat shock proteins in experimental atherosclerosis.

Authors:  I Rosier Olimpio Pereira; D Saes Parra Abdalla
Journal:  Eur J Nutr       Date:  2005-11-24       Impact factor: 5.614

2.  Soluble fiber and soybean protein reduce atherosclerotic lesions in guinea pigs. Sex and hormonal status determine lesion extension.

Authors:  E Cos; T Ramjiganesh; S Roy; S Yoganathan; R J Nicolosi; M L Fernandez
Journal:  Lipids       Date:  2001-11       Impact factor: 1.880

Review 3.  Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.

Authors:  C R Sirtori
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

4.  Soy isoflavones reduce electronegative low-density lipoprotein (LDL(-)) and anti-LDL (-) autoantibodies in experimental atherosclerosis.

Authors:  Nágila Raquel Teixeira Damasceno; Elaine Apolinário; Fabiana Dias Flauzino; Irene Fernandes; Dulcineia Saes Parra Abdalla
Journal:  Eur J Nutr       Date:  2007-01-30       Impact factor: 5.614

Review 5.  Soy proteins and cardiovascular disease.

Authors:  C R Sirtori; M R Lovati
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

6.  Dietary supplementation with soy isoflavones or replacement with soy proteins prevents hepatic lipid droplet accumulation and alters expression of genes involved in lipid metabolism in rats.

Authors:  Chao Wu Xiao; Carla M Wood; Dorcas Weber; Syed A Aziz; Rekha Mehta; Philip Griffin; Kevin A Cockell
Journal:  Genes Nutr       Date:  2013-11-30       Impact factor: 5.523

7.  Effect of soy proteins Vs soy isoflavones on lipid profile in postmenopausal women.

Authors:  H K Jassi; A Jain; Sarika Arora; R Chitra
Journal:  Indian J Clin Biochem       Date:  2010-05-27

Review 8.  Effects of botanical dietary supplements on cardiovascular, cognitive, and metabolic function in males and females.

Authors:  Scott Carlson; Ning Peng; Jeevan K Prasain; J Michael Wyss
Journal:  Gend Med       Date:  2008

9.  The α' subunit of β-conglycinin and the A1-5 subunits of glycinin are not essential for many hypolipidemic actions of dietary soy proteins in rats.

Authors:  Qixuan Chen; Carla Wood; Christine Gagnon; Elroy R Cober; Judith A Frégeau-Reid; Stephen Gleddie; Chao Wu Xiao
Journal:  Eur J Nutr       Date:  2013-11-26       Impact factor: 5.614

10.  Effects of a ferment soy product on the adipocyte area reduction and dyslipidemia control in hypercholesterolemic adult male rats.

Authors:  Nadia Carla Cheik; Elizeu Antônio Rossi; Ricardo Luís Fernandes Guerra; Neuli Maria Tenório; Cláudia Maria Oller do Nascimento; Fabiana Pavan Viana; Marla Simone Jovenasso Manzoni; Iracilda Zeponni Carlos; Patrícia Leão da Silva; Regina Célia Vendramini; Ana Raimunda Dâmaso
Journal:  Lipids Health Dis       Date:  2008-12-16       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.